OneMedRadio interviewed Thomas Braun, CEO of Verisante Technologies [CVE:VRS], a medical device company committed to commercializing innovative systems for the early detection of cancer.
RealBio Technology Transforms Research & Pharmaceutical Testing
RealBio’s technology allows cells grown in a laboratory setting to develop as they would in a normal human body.
T-Ray Science Announces Name Change
T-Ray Science, Inc., a medical device company committed to commercializing innovative systems for the early detection of cancer announces that shareholders approved a change of the name of the Company to Verisante Technology, Inc.
